Cargando…
Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease
Graves’ disease (GD) is a T cell-mediated organ-specific autoimmune disorder. GD patients who have taken anti-thyroid drugs (ATDs) for more than 5 years with positive anti-thyroid stimulating hormone receptor autoantibodies value were defined as persistent GD (pGD). To develop novel immunotherapies...
Autores principales: | Chen, Ziyi, Liu, Yufeng, Hu, Shiqian, Zhang, Meng, Shi, Bingyin, Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074859/ https://www.ncbi.nlm.nih.gov/pubmed/33912135 http://dx.doi.org/10.3389/fendo.2021.632492 |
Ejemplares similares
-
A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves’ orbitopathy
por: Wang, Yue, et al.
Publicado: (2021) -
Predicting the early risk of ophthalmopathy in Graves’ disease patients using TCR repertoire
por: Wang, Yue, et al.
Publicado: (2020) -
Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease
por: Gulbins, Anne, et al.
Publicado: (2023) -
Homeostasis and function of regulatory T cells (Tregs) in vivo: lessons from TCR-transgenic Tregs
por: Attridge, Kesley, et al.
Publicado: (2014) -
Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)